Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Marine Debris Polymers on Main Hawaiian Island Beaches, Sea Surface, and Seafloor.

Brignac KC, Jung MR, King C, Royer SJ, Blickley L, Lamson MR, Potemra JT, Lynch JM.

Environ Sci Technol. 2019 Oct 9. doi: 10.1021/acs.est.9b03561. [Epub ahead of print]

PMID:
31595747
2.

Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic Gliomas.

Omuro A, Beal K, McNeill K, Young RJ, Thomas A, Lin X, Terziev R, Kaley TJ, DeAngelis LM, Daras M, Gavrilovic IT, Mellinghoff I, Diamond EL, McKeown A, Manne M, Caterfino A, Patel K, Bavisotto L, Gorman G, Lamson M, Gutin P, Tabar V, Chakravarty D, Chan TA, Brennan CW, Garrett-Mayer E, Karmali RA, Pentsova E.

J Clin Oncol. 2018 Jun 10;36(17):1702-1709. doi: 10.1200/JCO.2017.76.9992. Epub 2018 Apr 23.

3.

Enhanced interfacial activity of multi-arm poly(ethylene oxide) star polymers relative to linear poly(ethylene oxide) at fluid interfaces.

Huang YR, Lamson M, Matyjaszewski K, Tilton RD.

Phys Chem Chem Phys. 2017 Sep 13;19(35):23854-23868. doi: 10.1039/c7cp02841e.

PMID:
28726899
4.

A pharmacokinetic study of lipegfilgrastim in children with Ewing family of tumors or rhabdomyosarcoma.

Belogurova MB, Kizyma ZP, Garami M, Csóka M, Lamson MJ, Buchner A, Bias P, Lammerich A.

Cancer Chemother Pharmacol. 2017 Jan;79(1):155-164. doi: 10.1007/s00280-016-3216-2. Epub 2016 Dec 16.

5.

Effect of food on the pharmacokinetics of oxycodone and naltrexone from ALO-02, an extended release formulation of oxycodone with sequestered naltrexone.

Gandelman K, Lamson M, Salageanu J, Bramson C, Matschke K, Malhotra B.

Clin Pharmacol Drug Dev. 2015 Sep;4(5):370-6. doi: 10.1002/cpdd.177. Epub 2015 Jan 22.

PMID:
27137146
6.

Synthesis and spectroscopic characterization of chiral biphenyl-cholesterol gels.

Geiger HC, Lamson M, Galka DJ.

Langmuir. 2014 Nov 25;30(46):13979-86. doi: 10.1021/la503954b. Epub 2014 Nov 11.

PMID:
25350932
7.

Tracking the sources and sinks of local marine debris in Hawai'i.

Carson HS, Lamson MR, Nakashima D, Toloumu D, Hafner J, Maximenko N, McDermid KJ.

Mar Environ Res. 2013 Mar;84:76-83. doi: 10.1016/j.marenvres.2012.12.002. Epub 2012 Dec 10.

PMID:
23268778
8.

Effects of concurrent intravenous morphine sulfate and naltrexone hydrochloride on end-tidal carbon dioxide.

Goli V, Webster LR, Lamson MJ, Cleveland JM, Sommerville KW, Carter E.

Harm Reduct J. 2012 Mar 15;9:13. doi: 10.1186/1477-7517-9-13.

9.

Pharmacokinetics of diazepam administered intramuscularly by autoinjector versus rectal gel in healthy subjects: a phase I, randomized, open-label, single-dose, crossover, single-centre study.

Lamson MJ, Sitki-Green D, Wannarka GL, Mesa M, Andrews P, Pellock J.

Clin Drug Investig. 2011;31(8):585-597. doi: 10.2165/11590250-000000000-00000.

PMID:
21721594
10.

A clinical trial demonstration of a web-based test for alcohol and drug effects.

Mills KC, Spruill SE, Walker JM, Lamson M.

J Stud Alcohol Drugs. 2009 Mar;70(2):308-13.

PMID:
19261244
11.

Pharmacokinetics and safety of binodenoson after intravenous dose escalation in healthy volunteers.

Barrett RJ, Lamson MJ, Johnson J, Smith WB.

J Nucl Cardiol. 2005 Mar-Apr;12(2):166-71.

PMID:
15812370
12.

Pharmacokinetics of lovastatin extended-release dosage form (Lovastatin XL) in healthy volunteers.

Lamson M, Phillips G, Shen J, Lukacsko P, Friedhoff L, Niecestro RM.

Biopharm Drug Dispos. 2002 May;23(4):143-9.

PMID:
12015788
13.

Pharmacokinetic interaction between nevirapine and ethinyl estradiol/norethindrone when administered concurrently to HIV-infected women.

Mildvan D, Yarrish R, Marshak A, Hutman HW, McDonough M, Lamson M, Robinson P.

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):471-7.

PMID:
11981363
14.

Pharmacokinetics of nevirapine and lamivudine in patients with HIV-1 infection.

Sabo JP, Lamson MJ, Leitz G, Yong CL, MacGregor TR.

AAPS PharmSci. 2000;2(1):E1.

15.

Single dose pharmacokinetics and bioavailability of nevirapine in healthy volunteers.

Lamson MJ, Sabo JP, MacGregor TR, Pav JW, Rowland L, Hawi A, Cappola M, Robinson P.

Biopharm Drug Dispos. 1999 Sep;20(6):285-91.

PMID:
10701699
16.

Disposition and biotransformation of the antiretroviral drug nevirapine in humans.

Riska P, Lamson M, MacGregor T, Sabo J, Hattox S, Pav J, Keirns J.

Drug Metab Dispos. 1999 Aug;27(8):895-901.

PMID:
10421616
17.

Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1.

Murphy RL, Sommadossi JP, Lamson M, Hall DB, Myers M, Dusek A.

J Infect Dis. 1999 May;179(5):1116-23.

PMID:
10191212
18.

Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection.

Luzuriaga K, Bryson Y, Krogstad P, Robinson J, Stechenberg B, Lamson M, Cort S, Sullivan JL.

N Engl J Med. 1997 May 8;336(19):1343-9.

19.

Pharmacokinetics, safety, and activity of nevirapine in human immunodeficiency virus type 1-infected children.

Luzuriaga K, Bryson Y, McSherry G, Robinson J, Stechenberg B, Scott G, Lamson M, Cort S, Sullivan JL.

J Infect Dis. 1996 Oct;174(4):713-21.

PMID:
8843207
20.

Prediction of acetaminophen level from clinical history of overdose using a pharmacokinetic model.

Edwards DA, Fish SF, Lamson MJ, Lovejoy FH Jr.

Ann Emerg Med. 1986 Nov;15(11):1314-9.

PMID:
3777589
21.

Use of the EOQ formula in hospital pharmacy purchasing.

Lamson MJ, Mahoney CD, Jeffrey LP.

Am J Hosp Pharm. 1982 Nov;39(11):1852, 1854. No abstract available.

PMID:
7148848
22.

Antibiotic-resistant group JK bacteria in hospitals.

Gill VJ, Manning C, Lamson M, Woltering P, Pizzo PA.

J Clin Microbiol. 1981 Mar;13(3):472-7.

23.

Surveillance of nosocomial infections by antibiotic monitoring.

Feldman L, Lamson M, Gallelli JF, Bennett JE.

JAMA. 1979 Jun 29;241(26):2806-7.

PMID:
448841
24.

Technetium-99m-human serum albumin: evaluation of a commercially produced kit.

Callahan RJ, McKusick KA, Lamson M 3rd, Castronovo FP, Potsaid MS.

J Nucl Med. 1976 Jan;17(1):47-9.

25.

Generator-produced 99m TcO4-: carrier free.

Lamson ML 3rd, Kirschner AS, Hotte CE, Lipsitz EL, Ice RD.

J Nucl Med. 1975 Jul;16(7):639-41.

26.

A rapid index of free activity in preparations of 99mTc-albumin.

Lamson M 3rd, Callahan RJ, Castronovo FP Jr, McKusick KA, Potsaid MS.

J Nucl Med. 1974 Nov;15(11):1061-2. No abstract available.

27.

A comparison of the frequency of hepatitis-B antigen and antibody in hospital and nonhospital personnel.

Lewis TL, Alter HJ, Chalmers TC, Holland PV, Purcell RH, Alling DW, Young D, Frenkel LD, Lee SL, Lamson ME.

N Engl J Med. 1973 Sep 27;289(13):647-51. No abstract available.

PMID:
4727967

Supplemental Content

Loading ...
Support Center